Advertisement
Advertisement

AADI

AADI logo

Aadi Bioscience Inc

2.29
USD
-0.1
-4.18%
Dec 18, 15:59 UTC -5
Closed
...

Aadi Bioscience Inc Profile

About

Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known as Aerpio Pharmaceuticals Inc., is based in LOS ANGELES.

Info & Links

CEO

David J. Lennon

Headquarters

17383 SUNSET AVENUE, SUITE A250
PACIFIC PALISADES, CA 90272, UNITED STATES

Auditor

BDO USA, P.C

Share holders

84

Employees

89

Aadi Bioscience Inc Statistics

Valuation Measures

Market Capitalization2

56.45M

Enterprise Value

25.91M

Enterprise Value/EBITDA(ttm)

-0.38

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.37

Price to Book(mrq)

0.86

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

87.36%

Operating Margin(ttm)

-246.06%

Profit Margin(ttm)

-252.20%

Return on Equity(ttm)

-71.87%

Return on Invested Capital(ttm)

-72.41%

Return on Assets(ttm)

-57.28%

Income Statement

Revenue(ttm)

25.07M

Revenue Per Share(ttm)

1.02

Gross Profit(ttm)

21.91M

EBITDA(ttm)3

-67.64M

Net Income Available to Common(ttm)

-61.69M

Diluted EPS(ttm)

-2.28

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

-55.36%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

24.65M

Dividend Yield

0.00%

Float4

15.45M

% Held by Insiders

37.30%

% Held by Institutions

52.08%

Balance Sheet

Total Cash(mrq)

62.62M

Total Cash Per Share(mrq)

2.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.89%

Quick Ratio(mrq)

4.54%

Book Value Per Share(mrq)

2.80

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.65

Free Cash Flow(ytd)

-45.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement